Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

NCT05918341 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Drug Adherence Marker

Interventions

DRUG: Piracetam

Sponsor

The Netherlands Cancer Institute